{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:37:46Z","timestamp":1790987866036,"version":"4.1.0"},"reference-count":143,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T00:00:00Z","timestamp":1252972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicinal Research Reviews"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiac hypertrophy allows the heart to adapt to workload, but persistent or unphysiological stimulus can result in pump failure. Cardiac hypertrophy is characterized by an increase in the size of differentiated cardiac myocytes. At the molecular level, growth of cells is linked to intensive transcription and translation. Several cyclin\u2010dependent kinases (CDKs) have been identified as principal regulators of transcription, and among these CDK9 is directly associated with cardiac hypertrophy. CDK9 phosphorylates the<jats:italic>C<\/jats:italic>\u2010terminal domain of RNA polymerase II and thus stimulates the elongation phase of transcription. Chronic activation of CDK9 causes not only cardiac myocyte enlargement but also confers predisposition to heart failure. Due to the long interest of molecular oncologists and medicinal chemists in CDKs as potential targets of anticancer drugs, a portfolio of small\u2010molecule inhibitors of CDK9 is available. Recent determination of CDK9's crystal structure now allows the development of selective inhibitors and their further optimization in terms of biochemical potency and selectivity. CDK9 may therefore constitute a novel target for drugs against cardiac hypertrophy. \u00a9 2009 Wiley Periodicals, Inc. Med Res Rev 30, No. 4, 646\u2013666, 2010<\/jats:p>","DOI":"10.1002\/med.20172","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T19:30:10Z","timestamp":1253043010000},"page":"646-666","source":"Crossref","is-referenced-by-count":42,"title":["Pharmacological targeting of CDK9 in cardiac hypertrophy"],"prefix":"10.1002","volume":"30","author":[{"given":"Vladim\u00edr","family":"Kry\u0161tof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Chamr\u00e1d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radek","family":"Jorda,","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Kohoutek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,9,15]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2219"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(02)00829-1"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2008.03.002"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.09.070"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000077012.11088.BC"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2007.04585.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.687947"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2008.02.020"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21094"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24178"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000120390.68287.BB"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2007.1474"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000018952.70505.F1"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1983"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2193"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2006.11.012"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvn137"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1110103"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.11.6729"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm778"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.5.755"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80939-3"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.02366-05"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl1138"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2007.21"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2006.06.014"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1091403"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.01.003"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2007.06.027"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn061"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.14.4859-4869.2003"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/35104581"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2443.2003.00618.x"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/35104575"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mod.2004.04.012"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2007.26"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.03.001"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2007.03.019"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.16.5897-5907.2000"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.18.6958-6969.2000"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310044200"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M502712200"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01316-08"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1636008"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M807495200"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00857-06"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01557-07"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2009.99"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2007.10.012"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/3-7643-7414-4_8"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2004.05.007"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2005.02.005"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1033.2003.03794.x"},{"key":"e_1_2_1_55_2","unstructured":"SchneiderMD SanoM.Modulators of CDK9 as a therapeutic target in cardiac hypertrophy. Baylor College of Medicine WO 2005\/027902 2005."},{"key":"e_1_2_1_56_2","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/S0021-9258(18)94169-4","article-title":"5,6\u2010Dichloro\u20101\u2010beta\u2010D\u2010ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro","volume":"264","author":"Chodosh LA","year":"1989","journal-title":"J Biol Chem"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(74)90220-4"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/272590a0"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.11.5750"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(83)80098-9"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.10.3167"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/5.9.3325"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.982026"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(76)90092-1"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.21.12335"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00352266"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.43.27176"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.11.20.2622"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.11.20.2633"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5376.533"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102306200"},{"key":"e_1_2_1_72_2","first-page":"2973","article-title":"Flavopiridol induces G1 arrest with inhibition of cyclin\u2010dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells","volume":"56","author":"Carlson BA","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.7.2735"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.1742"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2443.2003.00627.x"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.2174\/157340608784325205"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)00266-8"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2008.03.003"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2008.121"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2744(69)90420-3"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(79)63019-7"},{"key":"e_1_2_1_82_2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1096\/fj.04-1646fje","article-title":"Local cyclin\u2010dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug\u2010eluting stents to prevent neointima formation following vascular injury","volume":"18","author":"Jaschke B","year":"2004","journal-title":"FASEB J"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.6.659"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.170144197"},{"key":"e_1_2_1_85_2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0026-895X(24)12306-1","article-title":"The cyclin\u2010dependent kinase inhibitor roscovitine inhibits RNA synthesis and triggers nuclear accumulation of p53 that is unmodified at Ser15 and Lys382","volume":"60","author":"Ljungman M","year":"2001","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10738"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5185-1"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2184.2008.00549.x"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2001-2-10-research0041"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.4161\/cc.6.24.5142"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(02)00693-5"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm801340z"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0080"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.191"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2004.01.050"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4020(01)89673-3"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.05.015"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4020(01)89674-5"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1826"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm700940h"},{"key":"e_1_2_1_101_2","first-page":"6170","article-title":"A novel cdk2\u2010selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells","volume":"61","author":"Lane ME","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.024505"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637\u2010008\u20109211\u20107"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2006.06.003"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000194805.74293.11"},{"key":"e_1_2_1_106_2","doi-asserted-by":"crossref","unstructured":"ChenR WierdaWG BenaissaS HochU HawtinRE FoxJA KeatingMJ GandhiV PlunkettW.Mechanism of action of SNS\u2010032 a novel cyclin dependent kinase inhibitor in chronic lymphocytic leukemia: Comparison with flavopiridol. 49th Annual Meeting and Exposition of American Society for Hematology. Atlanta GA 8\u201311 December 2007.","DOI":"10.1182\/blood.V110.11.3112.3112"},{"key":"e_1_2_1_107_2","doi-asserted-by":"crossref","unstructured":"DiabS EckhardtS TanA FrenetteG GoreL DepintoW GrippoJ DM MikulskiS PapadimitrakopoulouS. A phase I study of R547 a novel selective inhibitor of cell cycle and transcriptional cyclin dependent kinases (CDKs). 43rd Annual Meeting of American Society of Clinical Oncology. Chicago IL 1\u20135 June2007.","DOI":"10.1200\/jco.2007.25.18_suppl.3528"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0309957"},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2006.04.048"},{"key":"e_1_2_1_110_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-0440"},{"key":"e_1_2_1_111_2","unstructured":"CaligiuriM BockovichN OalmannC KaplanF LamphereL WangS KlugeA KleyN.Induction of tumor regression by the broad\u2010spectrum cyclin dependent kinase inhibitor RGB\u2010286638. 97th Annual Meeting of the American Association for Cancer Research. Orlando FL 1\u20135 April 2006 ."},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0613"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.10.102"},{"key":"e_1_2_1_114_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1769"},{"key":"e_1_2_1_115_2","doi-asserted-by":"crossref","unstructured":"SquiresMS FeltellRE LockV SmithD LewisEJ HigginsJ YuleM ThompsonNT CookeL Croce DellaK QiW LyonsJF MahadevanD.AT7519 a potent CDK inhibitor is active in leukaemia models and primary CLL patient samples. 49th Annual Meeting and Exposition of American Society for Hematology. Atlanta GA 8\u201311 December 2007.","DOI":"10.1182\/blood.V110.11.3127.3127"},{"key":"e_1_2_1_116_2","doi-asserted-by":"crossref","unstructured":"HeuerTS.Discovery of Selective CDK9 Small Molecule Inhibitors: CDK9 Inhibition in Tumor Cells is Associated with Inhibition of Proliferation and Induction of Apoptosis. AACR\u2010NCI\u2010EORTC International Conference on Molecular Targets and Cancer Therapeutics. Geneva Switzerland; 21\u201324 October 2008.","DOI":"10.1016\/S1359-6349(08)72225-0"},{"key":"e_1_2_1_117_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0605740"},{"key":"e_1_2_1_118_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3940"},{"key":"e_1_2_1_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2005.08.008"},{"key":"e_1_2_1_120_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809674106"},{"key":"e_1_2_1_121_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809645106"},{"key":"e_1_2_1_122_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn1061"},{"key":"e_1_2_1_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(02)02071-0"},{"key":"e_1_2_1_124_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612053764850"},{"key":"e_1_2_1_125_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2559"},{"key":"e_1_2_1_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(02)00181-X"},{"key":"e_1_2_1_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00343-4"},{"key":"e_1_2_1_128_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm049323m"},{"key":"e_1_2_1_129_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0600388"},{"key":"e_1_2_1_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2004.08.013"},{"key":"e_1_2_1_131_2","doi-asserted-by":"publisher","DOI":"10.1002\/prot.10013"},{"key":"e_1_2_1_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2004.03.022"},{"key":"e_1_2_1_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2008.11.004"},{"key":"e_1_2_1_134_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102060200"},{"key":"e_1_2_1_135_2","doi-asserted-by":"publisher","DOI":"10.1002\/prot.340220408"},{"key":"e_1_2_1_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(02)00182-1"},{"key":"e_1_2_1_137_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvn215"},{"key":"e_1_2_1_138_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.625467"},{"key":"e_1_2_1_139_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707414"},{"key":"e_1_2_1_140_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(00)00124-4"},{"key":"e_1_2_1_141_2","doi-asserted-by":"publisher","DOI":"10.1038\/9035"},{"key":"e_1_2_1_142_2","unstructured":"HawtinE CoheR HaasN MendelsonD GordonM EderJP DezubeBJ AdelmanDC ShapiroGI HochU StockettDE ConroyA FoxJA.SNS\u2010032 exhibits dose\u2010dependent mechanism\u2010based inhibition of CDK7 and CDK9 in peripheral blood mononuclear cells from patients with advanced cancers treated in an ongoing phase 1 trial. 12th Congress of the European Hematology Association. Vienna Austria 7\u201310 June 2007."},{"key":"e_1_2_1_143_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0606138"},{"key":"e_1_2_1_144_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0355"}],"container-title":["Medicinal Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmed.20172","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/med.20172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T05:06:41Z","timestamp":1739336801000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/med.20172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,15]]},"references-count":143,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1002\/med.20172"],"URL":"https:\/\/doi.org\/10.1002\/med.20172","archive":["Portico"],"relation":{},"ISSN":["0198-6325","1098-1128"],"issn-type":[{"value":"0198-6325","type":"print"},{"value":"1098-1128","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,15]]}}}